NIH/CC

Medicine for the Public 2001 lecture series

Videos of the 2001 series will be available online after each lecture.

Medicine for the Public Logo. A white, purple and black sillouette image of five people's profiles

New therapies. Innovations in diagnostic procedures. How today's research will affect tomorrow's medicine.
Physician-scientists working at the forefront of medical research at the National Institutes of Health will examine these issues during the 2001 Medicine for the Public lecture series sponsored by the NIH Clinical Center.

For details on specific topics and speakers, please call (301) 496-2563. Or e-mail occc@cc.nih.gov.

The lectures, which are free and open to the public, are presented at 7 p.m. on Tuesdays in the Clinical Center's Masur Auditorium, National Institutes of Health, 9000 Rockville Pike, Building 10, Bethesda, Maryland.
Visitor access during heightened security | Maps and directions

Booklets based on selected Medicine for the Public lectures are available. Visit this site to order or call 301-496-2563.

Speakers/topics:

Videos of these lectures require the latest version of RealPlayer.

Sept. 25, 2001
Pain and Palliative Care: More Than Just End-of-Life Care
Ann Berger, R.N., M.S.N., M.D.
Chief, Pain and Palliative Care Service
Warren Grant Magnuson Clinical Center

00

Dr. Ann Berger will discuss how medicine works with other disciplines to care for the whole person to ease suffering during serious illness.

Oct. 2, 2001
The Sexually Transmitted Disease Epidemic: A Threat to the Nation's Public Health
Thomas Quinn, M.D.
Chief, International HIV/AIDS and STDs Section,
Laboratory of Immunoregulation
National Institute of Allergy and Infectious Diseases

00

Every year, about 12 million people acquire sexually transmitted diseases. These diseases lead to multiple complications, including infertility, ectopic pregnancies, chronic pain, and cancer. Most cases can be cured. All of them can be prevented. Dr. Thomas Quinn will discuss the incidence, the costs, the impact on society, and what can be done to decrease the risk of sexually transmitted diseases.

Oct. 9, 2001
New Strategies for the Detection and Treatment of Colon Cancer
Steven Libutti, M.D.
Senior Investigator, Surgery Branch
National Cancer Institute

00

Colon cancer strikes 130 thousand people a year. It is the second leading cause of cancer death in the United States, and has a mortality rate of nearly 50 percent. Dr. Steven Libutti will discuss how it is detected and treated. He will also discuss what new detection and treatment options are currently under study to increase survival, including local ablative therapy, anti-angiogenic therapy, and new ways to deliver chemotherapy.

Oct. 16, 2001
Breast Cancer: Progress and Promise
JoAnne Zujewski, M.D.
Senior Medical Oncologist, Center for Cancer Research
National Cancer Institute

00

Dr. Zujewski will discuss the risk factors for developing breast cancer and discuss current treatment options. She will review progress made in this disease and look at promising new research directions.

Oct. 23, 2001
Type I Diabetes: A Quest for Better Therapies
David Harlan, M.D.
Chief, Transplantation and Autoimmunity Branch
National Institute of Diabetes and Digestive and Kidney Diseases

00

Sixteen million people in the United States have diabetes; one million of them have type 1. It is the sixth leading cause of death in this country and often leads to blindness, heart and blood vessel disease, strokes, kidney failure, amputations, and nerve damage. Dr. David Harlan, will discuss the difference between type 1 and type 2 diabetes, then will focus on advances in how physicians might treat type 1 diabetes. HeÕll emphasize the latest research using islet transplantation and some other positive milestones to date.

Oct. 30, 2001
The Influenza Viruses and their Vaccines
Brian Murphy, M.D.
Co-Chief, Laboratory of Infectious Diseases
National Institute of Allergy and Infectious Diseases

00

About 10 to 20 percent of Americans are infected with the influenza virus each year. For most, the aches and pains associated with the flu come and go within a couple of weeks. However, an estimated 100,000 people are hospitalized and 20,000 deaths occur annually from the flu and its complications. Dr. Brian Murphy will explore the latest findings in flu vaccines, including a new influenza virus vaccine undergoing evaluation by the Food and Drug Administration.

Past lectures: 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997
Back to most current lectures

For more information about the Clinical Center,
e-mail occc@cc.nih.gov, or call Clinical Center Communications, 301-496-2563.

Warren Grant Magnuson Clinical Center
National Institutes of Health
Bethesda, Maryland 20892-7511

Speakers/topics:
Videos of these lectures require the latest version of RealPlayer.
Sept. 25, 2001 Pain and Palliative Care: More Than Just End-of-Life Care Ann Berger, R.N., M.S.N., M.D. Chief, Pain and Palliative Care Service Warren Grant Magnuson Clinical Center	00	Dr. Ann Berger will discuss how medicine works with other disciplines to care for the whole person to ease suffering during serious illness.
*Oct. 2, 2001* The Sexually Transmitted Disease Epidemic: A Threat to the Nation's Public Health Thomas Quinn, M.D. Chief, International HIV/AIDS and STDs Section, Laboratory of Immunoregulation National Institute of Allergy and Infectious Diseases	00	Every year, about 12 million people acquire sexually transmitted diseases. These diseases lead to multiple complications, including infertility, ectopic pregnancies, chronic pain, and cancer. Most cases can be cured. All of them can be prevented. Dr. Thomas Quinn will discuss the incidence, the costs, the impact on society, and what can be done to decrease the risk of sexually transmitted diseases.
Oct. 9, 2001 New Strategies for the Detection and Treatment of Colon Cancer Steven Libutti, M.D. Senior Investigator, Surgery Branch National Cancer Institute	00	Colon cancer strikes 130 thousand people a year. It is the second leading cause of cancer death in the United States, and has a mortality rate of nearly 50 percent. Dr. Steven Libutti will discuss how it is detected and treated. He will also discuss what new detection and treatment options are currently under study to increase survival, including local ablative therapy, anti-angiogenic therapy, and new ways to deliver chemotherapy.
Oct. 16, 2001 Breast Cancer: Progress and Promise JoAnne Zujewski, M.D. Senior Medical Oncologist, Center for Cancer Research National Cancer Institute	00	Dr. Zujewski will discuss the risk factors for developing breast cancer and discuss current treatment options. She will review progress made in this disease and look at promising new research directions.
Oct. 23, 2001 Type I Diabetes: A Quest for Better Therapies David Harlan, M.D. Chief, Transplantation and Autoimmunity Branch National Institute of Diabetes and Digestive and Kidney Diseases	00	Sixteen million people in the United States have diabetes; one million of them have type 1. It is the sixth leading cause of death in this country and often leads to blindness, heart and blood vessel disease, strokes, kidney failure, amputations, and nerve damage. Dr. David Harlan, will discuss the difference between type 1 and type 2 diabetes, then will focus on advances in how physicians might treat type 1 diabetes. HeÕll emphasize the latest research using islet transplantation and some other positive milestones to date.
*Oct. 30, 2001* The Influenza Viruses and their Vaccines Brian Murphy, M.D. Co-Chief, Laboratory of Infectious Diseases National Institute of Allergy and Infectious Diseases	00	About 10 to 20 percent of Americans are infected with the influenza virus each year. For most, the aches and pains associated with the flu come and go within a couple of weeks. However, an estimated 100,000 people are hospitalized and 20,000 deaths occur annually from the flu and its complications. Dr. Brian Murphy will explore the latest findings in flu vaccines, including a new influenza virus vaccine undergoing evaluation by the Food and Drug Administration.